{
    "clinical_study": {
        "@rank": "124388", 
        "arm_group": [
            {
                "arm_group_label": "Epidural analgesia", 
                "arm_group_type": "Active Comparator", 
                "description": "Epidural analgesia is provided with ropvacaine 0.2% given 6 hourly"
            }, 
            {
                "arm_group_label": "Continuous wound infusion", 
                "arm_group_type": "Experimental", 
                "description": "The continuous wound infusion consists of 0.376% ropivacaine infusion in the wound area at a rate 2 ml per hour."
            }
        ], 
        "brief_summary": {
            "textblock": "Study Hypothesis: The analgesic requirements and pain scores postoperatively differ between\n      the epidural and continuous wound infusion techniques."
        }, 
        "brief_title": "Epidural Versus Continuous Wound Ropivacaine Infusion Analgesia", 
        "completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "condition": "Postoperative Analgesia", 
        "detailed_description": {
            "textblock": "The analgesic requirements and pain scores postoperatively  differ between the epidural and\n      continuous wound infusion techniques, in patients undergoing myomectomy or hysterectomy."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Patients ASA I-II scheduled for abdominal hysterectomy or myomectomy -\n\n        Exclusion Criteria:\n\n        Age older than 60 and younger than 25 years, body weight exceeding the 30% of the ideal,\n        consumption of analgesics, sedatives, anxiolytics, antidepressants, calcium channel\n        blockers, CNS disease or insulin dependent diabetes\n\n        -"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01916473", 
            "org_study_id": "M-20/23-02-2010"
        }, 
        "intervention": [
            {
                "arm_group_label": "Epidural analgesia", 
                "description": "Epidural analgesia is provided with ropvacaine 0.2% given 6 hourly", 
                "intervention_name": "Epidural analgesia", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Continuous wound infusion", 
                "description": "Continuous wound infusion via catheter", 
                "intervention_name": "Continuous wound infusion", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Ropivacaine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Epidural analgesia", 
            "continuous wound infusion", 
            "ropivacaine", 
            "total abdominal hysterectomy"
        ], 
        "lastchanged_date": "August 1, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Athens", 
                    "country": "Greece", 
                    "zip": "11528"
                }, 
                "name": "Aretaieio Hospital"
            }
        }, 
        "location_countries": {
            "country": "Greece"
        }, 
        "number_of_arms": "2", 
        "official_title": "Epidural Versus Continuous Wound Ropivacaine Infusion: Effect on Acute and Chronic Pain After Myomectomy or Total Abdominal Hysterectomy. A Randomized Controlled Trial", 
        "overall_official": {
            "affiliation": "University of Athens", 
            "last_name": "Argyro Fassoulaki, MD,PhD, DEAA", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Greece: National Organization of Medicines", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Postoperative morphine consumption", 
                "safety_issue": "Yes", 
                "time_frame": "2 hours postoperatively"
            }, 
            {
                "measure": "Postoperative morphine consumption", 
                "safety_issue": "Yes", 
                "time_frame": "4 hours postoperatively"
            }, 
            {
                "measure": "Postoperative morphine consumption", 
                "safety_issue": "Yes", 
                "time_frame": "8 hours postoperatively"
            }, 
            {
                "measure": "Postoperative morphine consumption", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours postoperatively"
            }, 
            {
                "measure": "Postoperative morphine consumption", 
                "safety_issue": "Yes", 
                "time_frame": "48 hours postoperatively"
            }, 
            {
                "measure": "Postoperative morphine consumption", 
                "safety_issue": "Yes", 
                "time_frame": "72 hours postoperatively"
            }, 
            {
                "measure": "Postoperative morphine consumption", 
                "safety_issue": "Yes", 
                "time_frame": "3 months postoperatively"
            }, 
            {
                "measure": "Postoperative morphine consumption", 
                "safety_issue": "Yes", 
                "time_frame": "6 months postoperatively"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01916473"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Athens", 
            "investigator_full_name": "Argyro Fassoulaki", 
            "investigator_title": "Professor of Anesthesiology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "pain scores", 
                "safety_issue": "Yes", 
                "time_frame": "2 hours postoperatively"
            }, 
            {
                "measure": "pain scores", 
                "safety_issue": "Yes", 
                "time_frame": "4 hours postoperatively"
            }, 
            {
                "measure": "pain scores", 
                "safety_issue": "Yes", 
                "time_frame": "8 hours postoperatively"
            }, 
            {
                "measure": "pain scores", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours postoperatively"
            }, 
            {
                "measure": "pain scores", 
                "safety_issue": "Yes", 
                "time_frame": "48 hours postoperatively"
            }, 
            {
                "measure": "pain scores", 
                "safety_issue": "Yes", 
                "time_frame": "72 hours postoperatively"
            }, 
            {
                "measure": "pain scores", 
                "safety_issue": "Yes", 
                "time_frame": "3 months postoperatively"
            }, 
            {
                "measure": "pain scores", 
                "safety_issue": "Yes", 
                "time_frame": "6 months postoperatively"
            }
        ], 
        "source": "University of Athens", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Athens", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}